TY - JOUR
T1 - Combined Feedforward/Feedback Control of an Integrated Continuous Granulation Process
AU - Pereira, Glinka Cathy
AU - Muddu, Shashank Venkat
AU - Román-Ospino, Andrés David
AU - Clancy, Don
AU - Igne, Benoit
AU - Airiau, Christian
AU - Muzzio, Fernando J.
AU - Ierapetritou, Marianthi
AU - Ramachandran, Rohit
AU - Singh, Ravendra
PY - 2019/9/15
Y1 - 2019/9/15
N2 - Purpose: Continuous manufacturing offers shorter processing times and increased product quality assurance, among several other advantages. This makes it an ever-growing interest among pharmaceutical companies. A suitable efficient control system is however desired for continuous pharmaceutical manufacturing to achieve a consistent predefined end product quality. Methods: In order to control product quality more accurately, the effects of input disturbances need to be proactively mitigated. Therefore, it is desired that a combined feedforward/feedback control system integrated with suitable process analytical technology (PAT) be implemented over a traditional feedback-only control system. The feedforward controller measures and takes corrective actions for disturbances proactively before they affect the process and thereby product quality. The feedback controller considers the real-time deviation of control variable from a pre-specified set point and keeps it at a minimum possible value. The deviation of a control variable from the set point could be due to both measurable and unmeasurable disturbances. Results: In this work, a combined control strategy has been developed for a continuous twin screw wet granulation (WG) process. An integrated flowsheet model was developed and simulated in order to evaluate the effect of control loops on critical quality attributes (CQAs). Different strategies of manipulation were evaluated and the best strategy was identified. Conclusions: In silico study on the combined feedforward/feedback control strategy and feedback-only control strategy demonstrates that the combined loop results in diminished variability of the CQAs.
AB - Purpose: Continuous manufacturing offers shorter processing times and increased product quality assurance, among several other advantages. This makes it an ever-growing interest among pharmaceutical companies. A suitable efficient control system is however desired for continuous pharmaceutical manufacturing to achieve a consistent predefined end product quality. Methods: In order to control product quality more accurately, the effects of input disturbances need to be proactively mitigated. Therefore, it is desired that a combined feedforward/feedback control system integrated with suitable process analytical technology (PAT) be implemented over a traditional feedback-only control system. The feedforward controller measures and takes corrective actions for disturbances proactively before they affect the process and thereby product quality. The feedback controller considers the real-time deviation of control variable from a pre-specified set point and keeps it at a minimum possible value. The deviation of a control variable from the set point could be due to both measurable and unmeasurable disturbances. Results: In this work, a combined control strategy has been developed for a continuous twin screw wet granulation (WG) process. An integrated flowsheet model was developed and simulated in order to evaluate the effect of control loops on critical quality attributes (CQAs). Different strategies of manipulation were evaluated and the best strategy was identified. Conclusions: In silico study on the combined feedforward/feedback control strategy and feedback-only control strategy demonstrates that the combined loop results in diminished variability of the CQAs.
KW - Continuous pharmaceutical manufacturing
KW - Continuous twin screw granulator (TSG)
KW - Feedback control
KW - Feedforward control
KW - Process analytical technology
UR - http://www.scopus.com/inward/record.url?scp=85054522333&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054522333&partnerID=8YFLogxK
U2 - 10.1007/s12247-018-9347-8
DO - 10.1007/s12247-018-9347-8
M3 - Article
AN - SCOPUS:85054522333
SN - 1872-5120
VL - 14
SP - 259
EP - 285
JO - Journal of Pharmaceutical Innovation
JF - Journal of Pharmaceutical Innovation
IS - 3
ER -